Artificial intelligence has the potential to transform cardiovascular care by enabling novel diagnostics, digital biomarkers, and personalized medicine.
Artificial intelligence promises to transform cardiovascular care by enabling novel diagnostics, personalized medicine, and expanded access to screening.
Artificial intelligence (AI) has the potential to transform every facet of cardiovascular practice and research. The exponential rise in technology powered by AI is defining new frontiers in cardiovascular care, with innovations that span novel diagnostic modalities, new digital native biomarkers of disease, and high-performing tools evaluating care quality and prognosticating clinical outcomes. These digital innovations promise expanded access to cardiovascular screening and monitoring, especially among those without historical access to high-quality, specialized care. Moreover, AI is propelling biological and clinical discoveries that will make future cardiovascular care more personalized, precise, and effective. The review brings together these diverse AI innovations, highlighting developments in multimodal cardiovascular AI across clinical practice and biomedical discovery, envisioning this new future backed by contemporary science and emerging discoveries. Finally, we define the critical path and the safeguards essential to realizing this AI-enabled future that helps achieve optimal cardiovascular health and outcomes for all.
“Cardiology is uniquely positioned to lead medicine into the AI era. We will potentially lose some skills but will need to develop new ones, and so there will be an evolution of what it means to be a cardiologist.”
Khera et al. (Mon,) conducted a review in Cardiovascular disease. Artificial intelligence was evaluated. Artificial intelligence has the potential to transform cardiovascular care by enabling novel diagnostics, digital biomarkers, and personalized medicine.